Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (176484)	8/16/2021 12:35:43 PM
From: marcher	1 Recommendation Recommended By ggersh Respond to of 217781

--resident returning from the U.S. tested positive-- oh my, suggestion that the u.s. is the land of the unwashed. well, the author obviously hates the u.s. for its virus-freedom! -s?-

To: TobagoJack who wrote (176484)	8/16/2021 3:46:14 PM
From: marcher	Read Replies (3) \| Respond to of 217781

another one or one for all: "...Luke O’Neill on Ivermectin: Still not enough evidence to back drug as COVID treatment 16 Aug 2021 There is still not enough evidence to support the use of the drug Ivermectin as a COVID-19 treatment, according to Professor Luke O’Neill. ... Through the pandemic there have been growing calls for it to be used for the prevention and treatment of COVID-19 – with a number of studies showing it to be highly effective. ... Kory said he had no doubts about the drug’s effectiveness – and suggested health agencies were refusing to approve it because they have been ‘captured by Big Pharma.’ ...Trinity Professor Luke O’Neill said there are two major trials ongoing that should provide some answers, but the “jury is still out” on the studies that have been carried out to date. “If it works it will be great of course,” he said. “It is very cheap, it has been used for parasitic diseases, it is safe in humans – it has all the right things going for it. But the truth is, if you look at all the data combined, the jury is still out and we need more evidence to support it. There is some evidence out there absolutely. Several groups have looked at all of the data combined and there might be something going on but there are two massive trials running at the moment which is fantastic because it will really test it one way or another." “At the moment, in my view and in the view of many people looking at this, the jury is out still sadly but if it works, it will be great.” He said the main concern would be the high dosage that appears to be required – noting that many of the studies carried out so far were in the lab, rather than in humans. ... Bill Campbell himself, the man who discovered the drug remember – the man from Donegal who won the Nobel prize for Ivermectin for treating parasitic diseases – he said you may not reach that dosage in humans, let’s just wait and see. He was bit cautious about it.” He noted that one major study into the drug which found that it led to a 90% decrease in mortality was later withdrawn due to flaws and errors it contained. ...“If you look at them all combined and a very reputable organisation called the Cochrane Report - an independent body, they aren’t paid by drugs organisations let’s make that clear - they have assessed all the studies and they said at the moment the evidence isn’t there,” he said. “The Australian National COVID-19 Clinical Evidence Taskforce, they have assessed all the data and the WHO has as well and all three have said yes, there is a hint of something but let’s get better data to support it... newstalk.com